How can leaders keep pace with the ever-changing pharmaceutical industry? Cirrus CEO Simon Hayward talks to Diane Nowell at the FT Headspring website.
The pharmaceutical sector has been under the global spotlight like never before, and further challenges lie ahead. The drive to urgently research, test and release life-saving vaccines has heaped further strain on an industry already facing broader pressures from globalisation and technological advances, as well as from the sector-specific demands of healthcare reform, regulatory changes and patent churn.
The pandemic also served to accelerate digital transformation across the industry, as professionals had to rapidly pivot to new ways of working, at the same time ensuring the continuity of patient diagnosis, care and treatment. Some enforced changes – such as remote working – have had a positive impact, stimulating creative approaches to problem-solving and expanding global communication channels.
Leading through change
In a rapidly changing landscape, leaders who can navigate change while driving innovation and empowering others to create and implement new strategies, will outmanoeuvre their less agile contemporaries.
The rewards of agile innovation
Dr Simon Hayward is CEO of Cirrus and author of The Agile Leader and Connected Leadership. His research demonstrates how leaders can create transformative behavioural and cultural change through agile innovation. It’s an approach that has particular relevance to industries – like pharma – that are in flux.
“Agile leaders embrace disruption, and bring the outside in,” comments Simon. “They are also enablers – skilled at creating environments where people can collaborate to experiment, learn, and innovate. Often, this requires balancing risk and regulation – something pharmaceutical companies have always had to do in the pursuit of developing new and better solutions that meet customer needs, quickly.”
© FT Headspring 2021